Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section
NCT ID: NCT00891540
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
90 participants
INTERVENTIONAL
2009-07-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that systemic local infiltration will reduce pain and postoperative opioid consumption.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Vaginal Hysterectomy: a Randomized, Double-Blind Study
NCT00768456
Abdominal Wall Local Anesthesia to Maximize Postoperative Pain Control After Cesarean Delivery
NCT01261637
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
NCT02829944
Local Infiltration Analgesia With Ropivacaine in Posterior Vaginal Wall Prolapse:a Randomized, Double-Blind Study
NCT00769054
Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia
NCT02893423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Local infiltration with Ropivacaine
Ropivacaine
Ropivacaine 0.5%
2
Local infiltration with Ropivacaine
Ropivacaine
Ropivacaine 0.2%
3
Local infiltration with NaCl
placebo
Isotonic NaCl
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine
Ropivacaine 0.5%
Ropivacaine
Ropivacaine 0.2%
placebo
Isotonic NaCl
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to speak and understand Danish
* able to give informed consent
Exclusion Criteria
* allergies to local anesthetics
* age \< 18 years
* intolerance to opioids
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hvidovre University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hvidovre University Hospital
Copenhagen, Hvidovre, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-C-2009-019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.